ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
32 hedge funds and large institutions have $9.48M invested in Acorda Therapeutics in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less call options, than puts
Call options by funds: $ | Put options by funds: $
36% less capital invested
Capital invested by funds: $14.7M → $9.48M (-$5.26M)
Holders
32
Holding in Top 10
–
Calls
$179K
Puts
$203K
Top Buyers
| 1 | +$674K | |
| 2 | +$612K | |
| 3 | +$247K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$204K |
| 5 |
Millennium Management
New York
|
+$120K |
Top Sellers
| 1 | -$186K | |
| 2 | -$165K | |
| 3 | -$69K | |
| 4 |
Two Sigma Investments
New York
|
-$50K |
| 5 |
Renaissance Technologies
New York
|
-$25.2K |